These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 27862098)
21. Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism. Sekine Y; Nakayama H; Miyazawa Y; Kato H; Furuya Y; Arai S; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K Oncol Lett; 2018 Mar; 15(3):3167-3172. PubMed ID: 29435052 [TBL] [Abstract][Full Text] [Related]
22. Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells. Sato R; Yamasaki M; Hirai K; Matsubara T; Nomura T; Sato F; Mimata H Oncol Rep; 2015 Jan; 33(1):58-66. PubMed ID: 25370833 [TBL] [Abstract][Full Text] [Related]
23. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479 [TBL] [Abstract][Full Text] [Related]
24. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells. Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308 [TBL] [Abstract][Full Text] [Related]
25. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells. Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372 [TBL] [Abstract][Full Text] [Related]
26. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2). Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254 [TBL] [Abstract][Full Text] [Related]
27. Fibroblast activation protein-alpha knockdown suppresses prostate cancer cell invasion and proliferation. An J; Hou D; Wang L; Wang L; Yang Y; Wang H Histol Histopathol; 2022 Jun; 37(6):597-607. PubMed ID: 35129203 [TBL] [Abstract][Full Text] [Related]
28. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth. Yang F; Song L; Wang H; Wang J; Xu Z; Xing N PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145 [TBL] [Abstract][Full Text] [Related]
29. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma. Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922 [TBL] [Abstract][Full Text] [Related]
30. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance. Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648 [TBL] [Abstract][Full Text] [Related]
31. Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells. Holzmann C; Kappel S; Kilch T; Jochum MM; Urban SK; Jung V; Stöckle M; Rother K; Greiner M; Peinelt C Oncotarget; 2015 Dec; 6(39):41783-93. PubMed ID: 26496025 [TBL] [Abstract][Full Text] [Related]
32. Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion. Li Y; Ligr M; McCarron JP; Daniels G; Zhang D; Zhao X; Ye F; Wang J; Liu X; Osman I; Mencher SK; Lepor H; Wang LG; Ferrari A; Lee P Clin Cancer Res; 2011 Jul; 17(13):4414-24. PubMed ID: 21606178 [TBL] [Abstract][Full Text] [Related]
33. CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells. Ishikura N; Kawata H; Nishimoto A; Nakamura R; Tsunenari T; Watanabe M; Tachibana K; Shiraishi T; Yoshino H; Honma A; Emura T; Ohta M; Nakagawa T; Houjo T; Corey E; Vessella RL; Aoki Y; Sato H Int J Oncol; 2015 Apr; 46(4):1560-72. PubMed ID: 25634071 [TBL] [Abstract][Full Text] [Related]
34. [Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells]. Yang N; Wang L; Chen X; Liu J; Luo Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):821-4. PubMed ID: 27371852 [TBL] [Abstract][Full Text] [Related]
35. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway. Wei T; Zhu X J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966 [TBL] [Abstract][Full Text] [Related]
36. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145. Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322 [TBL] [Abstract][Full Text] [Related]
37. Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation. Guo Z; Xing Z; Cheng X; Fang Z; Jiang C; Su J; Zhou Z; Xu Z; Holmberg A; Nilsson S; Liu Z PLoS One; 2015; 10(5):e0124292. PubMed ID: 26010447 [TBL] [Abstract][Full Text] [Related]
38. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters. Otsuki H; Kimura T; Yamaga T; Kosaka T; Suehiro JI; Sakurai H Prostate; 2017 Feb; 77(2):222-233. PubMed ID: 27696482 [TBL] [Abstract][Full Text] [Related]
39. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion. Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176 [TBL] [Abstract][Full Text] [Related]
40. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma. Kim J; Kim MA; Jee CD; Jung EJ; Kim WH Int J Cancer; 2009 Oct; 125(8):1842-50. PubMed ID: 19582876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]